In breast cancer, CREB3L4 has been shown to bind to the promoter region of proliferating cell nuclear antigen (PCNA), with knockdown of CREB3L4 increasing cell apoptosis and cell cycle arrest [129]. Here, CREB3L4 is linked to breast cancer.